Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

Published:2022-04 Issue:4 Volume:9 Page:e262-e275
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Marks David I,Kirkwood Amy A,Rowntree Clare J,Aguiar Melanie,Bailey Katharine E,Beaton Brendan,Cahalin Paul,Castleton Anna Z,Clifton-Hadley Laura,Copland Mhairi,Goldstone Anthony H,Kelly Richard,Lawrie Emma,Lee SooWah,McMillan Andrew K,McMullin Mary Frances,Menne Tobias F,Mitchell Rachel J,Moorman Anthony V,Patel Bela,Patrick Pip,Smith Paul,Taussig David,Yallop Deborah,Alapi Krisztina Zuborne,Fielding Adele K

Funder

Cancer Research UK

Blood Cancer UK

Publisher

Elsevier BV

Subject

Hematology

Reference16 articles.

1. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia;Thomas;J Clin Oncol,2010

2. Rituximab in B-lineage adult acute lymphoblastic leukemia;Maury;N Engl J Med,2016

3. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy;Dworzak;Blood,2008

4. Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia;Maury;Haematologica,2010

5. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia;Thomas;Blood,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL);Current Treatment Options in Oncology;2024-08-05

2. Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review;JAMA Network Open;2024-06-03

3. Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia;Haematologica;2024-05-10

4. Management of ALL in adults: 2024 ELN recommendations from a European expert panel;Blood;2024-05-09

5. How I treat newly diagnosed acute lymphoblastic leukemia;Clinical Hematology International;2024-05-09